Interestingly, we demonstrated that delirium in LPS-treated CCH rats was associated with reduced hippocampal QA, suggesting a possible neuroprotective activity from IDO activation via endotoxin tolerance. This evidence concerns the gene IDO1 and columnar cell hyperplasia of the breast.